试验名为IDEAL（经皮艾斯能治疗治疗阿尔茨海默氏病调查）临床试验，纳入近1200例轻至中度阿尔茨海默病患者。
The trial was called the international IDEAL (Investigation of Transdermal Exelon in ALzheimer's disease) clinical trial and involved nearly 1,200 patients with mild to moderate Alzheimer's disease.
试验名为IDEAL（经皮艾斯能治疗治疗阿尔茨海默氏病调查）临床试验，纳入近1200例轻至中度阿尔茨海默病患者。
The trial was called the international IDEAL (Investigation of Transdermal Exelon in ALzheimer's disease) clinical trial and involved nearly 1,200 patients with mild to moderate Alzheimer's disease.
应用推荐